Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Theravance Biopharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
TBPH
Nasdaq
2834
https://www.theravance.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Theravance Biopharma Inc
Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
- Mar 27th, 2024 3:30 pm
Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics
- Mar 12th, 2024 7:59 pm
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 3:35 pm
Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
- Feb 27th, 2024 4:47 pm
Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates
- Feb 26th, 2024 10:25 pm
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Feb 26th, 2024 9:05 pm
Theravance Biopharma to Participate in an Upcoming Investor Conference
- Feb 22nd, 2024 11:00 am
Will Theravance Biopharma (NASDAQ:TBPH) Spend Its Cash Wisely?
- Feb 15th, 2024 12:07 pm
Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
- Feb 14th, 2024 11:00 am
Analysts Expect Breakeven For Theravance Biopharma, Inc. (NASDAQ:TBPH) Before Long
- Jan 19th, 2024 10:59 am
Down -11.17% in 4 Weeks, Here's Why Theravance Bio (TBPH) Looks Ripe for a Turnaround
- Jan 12th, 2024 2:35 pm
Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
- Jan 5th, 2024 11:00 am
7 Short-Squeeze Stocks That Are Screaming for Speculation
- Dec 24th, 2023 6:08 pm
Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors
- Dec 21st, 2023 10:00 pm
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference
- Dec 18th, 2023 11:00 am
The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable
- Dec 9th, 2023 1:35 pm
Theravance Bio (TBPH) Up 2.5% Since Last Earnings Report: Can It Continue?
- Dec 7th, 2023 4:30 pm
Billionaire Seth Klarman’s Biotech Stock Picks
- Nov 22nd, 2023 2:14 pm
Theravance Biopharma to Present New Ampreloxetine Data at the 34th International Symposium on The Autonomic Nervous System
- Nov 16th, 2023 11:00 am
Theravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx Conference
- Nov 15th, 2023 11:00 am
Scroll